Immunotherapy advances in triple-negative breast cancer drive personalized treatments with immune checkpoint inhibitors, aiding subtype identification and new combination therapy developments.

Posters presented at the Association of Cancer Care Centers opening session covered initiatives to boost clinical trial ...

today announced the acceptance of two abstracts for poster presentations at the upcoming Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific Meeting taking place March 12-14 ...

An expanded access program evaluating cretostimogene grenadenorepvec was highlighted during the 25th Annual Meeting of the ...

He’s worked on album covers for the likes of Madonna and Michael Jackson and sold artwork to the Beckhams and the Obamas.

CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ ...

Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and ...

ADCs are currently at the forefront of cancer treatment, but persistent drug development challenges call for a new approach.

Cancer Research & Oncology 2025 will offer a 1-day content-rich program providing invited lectures, thought-provoking discussions and posters to explore global developments and advancements in the ...

In our ‘think like a scientist’ challenge, students design and run an experiment based on enzymes and cancer. By leading their own research and showcasing the results in a scientific poster, students ...

The video producer had made a sudden sea change, leaving her stressful office job in Sydney for a more relaxed lifestyle in ...